A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)
Acute Kidney Injury (Nontraumatic), Pneumoperitoneum
About this trial
This is an interventional diagnostic trial for Acute Kidney Injury (Nontraumatic)
Eligibility Criteria
Inclusion Criteria: Patients aged 18-70 years of both sexes ASA I-III Patients Exclusion Criteria: Obesity, Chronic Kidney Disease, Chronic Renal Failure, Acute Renal Failure, Peripheral and ischemic vascular disease, Chronic Heart Failure, History of anaphylaxis, A-V block, Creatinine level >1.4, Neuromuscular disease, Malignant hypertension, Pyelonephritis, Urinary tract infectio, Severe inflammation/possible sepsis, Active malignancy, Patients with surgery reversion to laparotomy, Hemodynamic instability, need for vasopressors, Severe bleeding requiring blood transfusion,
Sites / Locations
Arms of the Study
Arm 1
Other
IGF
Creatinine and NGAL have been used successfully in the follow-up of acute kidney injury. In our study, in order to show the effect of pneumoperitoneum on acute kidney injury in patients scheduled for laparoscopic surgery, NGAL and IGF-1 values will be measured before, after and 24 hours after pneumoperitoneum, and these values will be compared.